Your browser doesn't support javascript.
loading
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Ceriani, Luca; Martelli, Maurizio; Gospodarowicz, Maria K; Ricardi, Umberto; Ferreri, Andrés J M; Chiappella, Annalisa; Stelitano, Caterina; Balzarotti, Monica; Cabrera, Maria E; Cunningham, David; Guarini, Attilio; Zinzani, Pier Luigi; Giovanella, Luca; Johnson, Peter W M; Zucca, Emanuele.
Afiliação
  • Ceriani L; Nuclear Medicine and PET-CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. Electronic address: luca.ceriani@eoc.ch.
  • Martelli M; Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Gospodarowicz MK; Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Ricardi U; Department of Oncology, University of Torino, Torino, Italy.
  • Ferreri AJ; Unit of Lymphoid Malignancies, Department of Onco-Hematology, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy.
  • Chiappella A; Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy.
  • Stelitano C; Hematology, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
  • Balzarotti M; Hematology, IRCCS Humanitas Cancer Center, Rozzano, Milan, Italy.
  • Cabrera ME; Hematology, Hospital del Salvador, Universidad de Chile, Santiago, Chile.
  • Cunningham D; Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London and Surrey, United Kingdom.
  • Guarini A; Hematology Unit, Istituto Nazionale Tumori Giovanni Paolo II IRCCS, Bari, Italy.
  • Zinzani PL; Institute of Hematology and Medical Oncology, Policlinico S.Orsola-Malpighi, Bologna, Italy.
  • Giovanella L; Nuclear Medicine and PET-CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Johnson PW; Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom.
  • Zucca E; Oncology Department, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Int J Radiat Oncol Biol Phys ; 97(1): 42-49, 2017 01 01.
Article em En | MEDLINE | ID: mdl-27839910

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Imunoterapia / Neoplasias do Mediastino Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Imunoterapia / Neoplasias do Mediastino Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2017 Tipo de documento: Article